Grant Verstandig - Apr 4, 2023 Form 4 Insider Report for NexImmune, Inc. (NEXI)

Role: Director
Signature: /s/ John Rudy, attorney-in-fact
Stock symbol: NEXI
Transactions as of: Apr 4, 2023
Transactions value $: $0
Form type: 4
Date filed: 4/6/2023, 08:42 PM
Previous filing: Jun 15, 2022
Next filing: Jul 7, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Shares	Change %	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NEXI	Stock Option (right to buy)	Disposed to Issuer	-61.7K	-100%	0	Apr 4, 2023	Common Stock	61.7K	$1.82	Direct	F1
transaction	NEXI	Stock Option (right to buy)	Award	+61.7K		61.7K	Apr 4, 2023	Common Stock	61.7K	$1.64	Direct	F1
transaction	NEXI	Stock Option (right to buy)	Disposed to Issuer	-39.1K	-100%	0	Apr 4, 2023	Common Stock	39.1K	$17.00	Direct	F2
transaction	NEXI	Stock Option (right to buy)	Award	+33.7K		33.7K	Apr 4, 2023	Common Stock	33.7K	$1.64	Direct	F2
transaction	NEXI	Stock Option (right to buy)	Award	+5.43K		5.43K	Apr 4, 2023	Common Stock	5.43K	$1.23	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on June 13, 2022, of which all of the shares subject to such option will vest on June 13, 2023, subject to Mr. Verstandig's continued service on such vesting date.
F2	The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 11, 2021, 27,150 shares of which have vested, and the remainder of the options will vest in equal monthly installments such that on February 11, 2025, all shares subject to the option shall be vested, subject to Mr. Verstandig's continued service on each vesting date.

Content

The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on June 13, 2022, of which all of the shares subject to such option will vest on June 13, 2023, subject to Mr. Verstandig's continued service on such vesting date.

The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 11, 2021, 27,150 shares of which have vested, and the remainder of the options will vest in equal monthly installments such that on February 11, 2025, all shares subject to the option shall be vested, subject to Mr. Verstandig's continued service on each vesting date.